Health Canada states that SGLT-2 inhibitors are drugs designed to lower blood sugar in adults with Type 2 diabetes by helping remove excess sugar from the body through the urine, while DPP-4 inhibitors are also used to treat Type 2 diabetes in adults alongside an appropriate diet and exercise to control blood sugar. In some cases, DPP-4 inhibitors are also used with another anti-diabetic drug
Randomized Clinical Trial of How Long-Term Glutathione Supplementation Offers Protection from Oxidative Damage and Improves HbA1c in Elderly Type 2 Diabetic Patients
By acting as a mobile copper donor, GHK-Cu is hypothesized to support the activity of these enzymes, linking copper delivery to both structural remodeling and antioxidant defense
Recent funding from the Congressionally Directed Medical Research Program will support a multi-site study that should kick off by the end of the year, and Schacht suspects approval of a GLP-1 drug for AUD in less than three years
There can be side effects and risks: GLP-1 drugs affect multiple systems (pancreas, kidney, GI tract) and are not without cost or health implications